Physician profile
Ruby S Ali
NPI 1093990426
$19,193.10
in general payments reported to CMS, 2019-2025
62 companies · $4,163 in 2025
The $4,163 reported for 2025 was more than what 83% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,586 · 2020: $1,074 · 2021: $2,643 · 2022: $2,371 · 2023: $2,771 · 2024: $4,585 · 2025: $4,163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,421 · Travel and Lodging: $2,045 · Education: $53.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,421.17 |
| Travel and Lodging | $2,044.86 |
| Education | $53.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $4,591.52 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Livanova USA, INC. | $3,365.84 | 2019-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Ucb, INC. | $1,057.08 | 2019-2025 | Rystiggo, Fintepla, Zilbrysq |
| Biogen, INC. | $964.91 | 2019-2025 | Vumerity, Tysabri |
| Allergan, INC. | $839.71 | 2019-2022 | |
| Pfizer INC. | $637.23 | 2019-2025 | |
| Genzyme Corporation | $489.49 | 2019-2023 | |
| Sk Life Science, INC. | $466.78 | 2020-2024 | |
| Novartis Pharmaceuticals Corporation | $443.89 | 2019-2025 | |
| Biohaven Pharmaceuticals, INC. | $381.97 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $379.16 | 2019-2024 | Austedo Xr |
| Emd Serono, INC. | $366.65 | 2019-2024 | Mavenclad |
| Acadia Pharmaceuticals INC | $364.06 | 2019-2025 | Nuplazid, Daybue |
| Janssen Biotech, INC. | $362.43 | 2021-2025 | Stelara, Simponi Aria, Remicade |
| Celgene Corporation | $353.83 | 2021-2024 | Zeposia |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amneal Pharmaceuticals LLC | $320.35 | 2022-2025 | Rytary, Crexont |
| Lilly USA, LLC | $280.88 | 2019-2024 | Amyvid, Emgality |
| Biohaven Pharmaceutical Holding Company LTD. | $226.94 | 2022 | |
| Scilex Pharmaceuticals INC. | $197.00 | 2023-2025 | Ztlido, Elyxyb |
| Merz Pharmaceuticals, LLC | $191.50 | 2021-2025 | Xeomin, Inbrija |
| Takeda Pharmaceuticals U.S.A., INC. | $184.73 | 2021-2025 | Entyvio |
| Argenx US, INC. | $175.77 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Janssen Pharmaceuticals, INC | $175.38 | 2021-2022 | |
| Tanabe Pharma America, INC. | $168.05 | 2023-2025 | Radicava |
| Alexion Pharmaceuticals, INC. | $155.29 | 2023-2024 | Ultomiris |
| Horizon Therapeutics Plc | $154.38 | 2022 | |
| Amgen INC. | $131.21 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $129.86 | 2023-2025 | |
| Aucta Pharmaceuticals, INC. | $119.78 | 2024-2025 | Motpoly Xr |
| Banner Life Sciences, LLC | $114.31 | 2022-2024 | |
| Eisai INC. | $96.32 | 2022-2024 | |
| Neurocrine Biosciences, INC. | $95.54 | 2019-2022 | |
| Ge Healthcare | $92.86 | 2019-2024 | |
| Genentech USA, INC. | $81.32 | 2023-2025 | Ocrevus, Ocrevus Zunovo |
| Lundbeck LLC | $77.96 | 2022-2023 | Vyepti |
| Intercept Pharmaceuticals, INC. | $76.05 | 2020-2023 | Ocaliva |
| Integra Lifesciences Corporation | $68.74 | 2021-2023 | Duraseal Exact Spinal Sealant System, Codman Hakim, Codman Certas |
| Mdd US Operations, LLC | $61.25 | 2019 | |
| Redhill Biopharma INC. | $59.18 | 2022-2023 | Movantik, Talicia, Aemcolo |
| Adamas Pharmaceuticals, INC. | $59.09 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $55.80 | 2019-2021 | |
| Greenwich Biosciences, INC. | $54.48 | 2020-2021 | |
| Axsome Therapeutics, INC. | $51.08 | 2025 | Symbravo |
| Kyowa Kirin, INC. | $43.64 | 2024 | Nourianz |
| Neurelis, INC. | $38.24 | 2021 | |
| Neuropace, INC. | $38.23 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $35.71 | 2025 | Rexulti |
| Ani Pharmaceuticals, INC. | $33.01 | 2023 | Purified Cortrophin Gel |
| Merz North America, INC. | $26.59 | 2019 | |
| Promius Pharma LLC | $25.01 | 2019 | |
| Ethicon US, LLC | $23.18 | 2022 | |
| Braintree Laboratories, INC. | $22.92 | 2023 | Sutab |
| Impel Pharmaceuticals INC. | $21.75 | 2023 | Trudhesa |
| Tg Therapeutics, INC. | $21.43 | 2023 | |
| Baxter Healthcare | $21.35 | 2025 | Hillrom - Monarch Airway Clearance System |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $20.79 | 2025 | Rexulti |
| Csl Behring | $19.36 | 2019 | |
| Avanir Pharmaceuticals, INC. | $18.44 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.89 | 2021 | |
| Genentech, INC. | $16.52 | 2024 | Ocrevus |
| Vertical Pharmaceuticals, LLC | $14.84 | 2019 | |
| Glaxosmithkline, LLC. | $14.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruby Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.